"Vitalant-one of the nation's oldest and largest non-profit community blood service providers-supplies comprehensive transfusion medicine services for nearly 1,000 hospitals and health care partners for patients in need across 40 states. Vitalant inspires local communities to serve the needs of others and transform lives through the selfless act of donating blood. It operates a world-renowned transfusion medicine research institute, owns a biological products distribution service and co-owns a high-volume donor testing laboratory joint venture."

During the past decade, Bonfils Blood Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bonfils Blood Center" are "Healthy Volunteers" (3 trials) and "Granulocyte/ Polymorphonuclear Cells" (1 trials). Many other conditions were trialed in "Bonfils Blood Center" in a lesser frequency.

Most popular intervention types in "Bonfils Blood Center" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Trima Accel System with Version 7.0 Software" (2 trials), "Granulocyte/Polymorphonuclear Cell Collection (COBE Spectra System)" (1 trials), "Granulocyte/Polymorphonuclear Cell Collection (Spectra Optia System)" (1 trials) and "Trima Accel System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bonfils Blood Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Bonfils Blood Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Bonfils Blood Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bonfils Blood Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".